191 related articles for article (PubMed ID: 34572563)
1. Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long Glycosaminoglycans.
Marcisz M; Maszota-Zieleniak M; Huard B; Samsonov SA
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572563
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of replica exchange with repulsive scaling approach for docking glycosaminoglycans.
Maszota-Zieleniak M; Marcisz M; Kogut MM; Siebenmorgen T; Zacharias M; Samsonov SA
J Comput Chem; 2021 Jun; 42(15):1040-1053. PubMed ID: 33768554
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
González-Mendióroz M; Alvarez-Vázquez AB; Rubio-Martinez J
J Mol Graph Model; 2013 Feb; 39():13-22. PubMed ID: 23202984
[TBL] [Abstract][Full Text] [Related]
4. Repulsive Scaling Replica Exchange Molecular Dynamics in Modeling Protein-Glycosaminoglycan Complexes.
Marcisz M; Maszota-Zieleniak M; Samsonov SA
Methods Mol Biol; 2023; 2619():153-167. PubMed ID: 36662469
[TBL] [Abstract][Full Text] [Related]
5. Further analyses of APRIL/APRIL-receptor/glycosaminoglycan interactions by biochemical assays linked to computational studies.
Marcisz M; Huard B; Lipska AG; Samsonov SA
Glycobiology; 2021 Aug; 31(7):772-786. PubMed ID: 33682874
[TBL] [Abstract][Full Text] [Related]
6. Explicit solvent repulsive scaling replica exchange molecular dynamics (RS-REMD) in molecular modeling of protein-glycosaminoglycan complexes.
Marcisz M; Gaardløs M; Bojarski KK; Siebenmorgen T; Zacharias M; Samsonov SA
J Comput Chem; 2022 Sep; 43(24):1633-1640. PubMed ID: 35796487
[TBL] [Abstract][Full Text] [Related]
7. In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.
Silva JH; Calmon-Hamaty F; Savino W; Hahne M; Caffarena ER
Protein Pept Lett; 2015; 22(5):432-42. PubMed ID: 25731591
[TBL] [Abstract][Full Text] [Related]
8. Coarse-grained model of glycosaminoglycans.
Samsonov SA; Bichmann L; Pisabarro MT
J Chem Inf Model; 2015 Jan; 55(1):114-24. PubMed ID: 25490039
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
10. The design and characterization of receptor-selective APRIL variants.
Kimberley FC; van der Sloot AM; Guadagnoli M; Cameron K; Schneider P; Marquart JA; Versloot M; Serrano L; Medema JP
J Biol Chem; 2012 Oct; 287(44):37434-46. PubMed ID: 22961987
[TBL] [Abstract][Full Text] [Related]
11. Docking glycosaminoglycans to proteins: analysis of solvent inclusion.
Samsonov SA; Teyra J; Pisabarro MT
J Comput Aided Mol Des; 2011 May; 25(5):477-89. PubMed ID: 21597992
[TBL] [Abstract][Full Text] [Related]
12. Modeling Protein-Glycosaminoglycan Complexes: Does the Size Matter?
Marcisz M; Zacharias M; Samsonov SA
J Chem Inf Model; 2021 Sep; 61(9):4475-4485. PubMed ID: 34494837
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of a variant of TACI (CRD2-shortTACIFc) in Pichia pastoris.
Wang R; Zhou S; Peng X; Zhou XW; Xie ZQ; Wang Y; Mo W; Yu M
Protein Pept Lett; 2012 Mar; 19(3):315-25. PubMed ID: 21933134
[TBL] [Abstract][Full Text] [Related]
14. Computational drill down on FGF1-heparin interactions through methodological evaluation.
Babik S; Samsonov SA; Pisabarro MT
Glycoconj J; 2017 Jun; 34(3):427-440. PubMed ID: 27858202
[TBL] [Abstract][Full Text] [Related]
15. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
16. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
17. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.
Gupta M; Dillon SR; Ziesmer SC; Feldman AL; Witzig TE; Ansell SM; Cerhan JR; Novak AJ
Blood; 2009 May; 113(21):5206-16. PubMed ID: 19321861
[TBL] [Abstract][Full Text] [Related]
18. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dynamics Approaches Dissect Molecular Mechanisms Underlying Methylene Blue-Glycosaminoglycan Interactions.
Maszota-Zieleniak M; Zsila F; Samsonov SA
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566005
[TBL] [Abstract][Full Text] [Related]
20. Modeling large protein-glycosaminoglycan complexes using a fragment-based approach.
Samsonov SA; Zacharias M; Chauvot de Beauchene I
J Comput Chem; 2019 May; 40(14):1429-1439. PubMed ID: 30768805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
